Search - tctmd.com

Displaying 241 - 260 of 294

Sort: Relevancy | Date

News Daily News

Debut of DES Failed to Alter Survival Benefit of CABG vs PCI in Multivessel Disease

L.A. McKeown

November 06, 2014

News Daily News

TWENTE: Second-Generation DES Show Good Long-term Outcomes in Bifurcation Lesions

L.A. McKeown

November 02, 2014

News Daily News

DES Linked With Lower In-Hospital Mortality Than BMS for All PCI Indications

Todd Neale

October 03, 2014

News Conference News TCT 2014

Long-term Outcomes Worse for Patients with Coronary Artery Aneurysm After DES Implantation

Yael L. Maxwell

September 19, 2014

News Daily News

Clinical Impact of DES Failure Depends on Timing

L.A. McKeown

August 07, 2014

News Daily News

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

Todd Neale

July 24, 2014

News Daily News

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

Yael L. Maxwell

July 03, 2014

News Conference News EuroPCR 2014

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

Caitlin E. Cox

May 20, 2014

News Daily News

Long-term Outcomes of ‘Full Metal Jacket’ Stenting Appear Favorable

April 30, 2014

News Daily News

Las Mejoras en la Revascularización No Logran Reducir la Mortalidad por Todas las Causas en Japón

Caitlin E. Cox

March 20, 2014

News Daily News

Improvements in Revascularization Reduce Cardiac Death, MI and Repeat Revascularization, but not All-Cause Mortality in Japan

Caitlin E. Cox

March 20, 2014

News Daily News

Los Resultados SLF Varían según el Estado de la Diabetes y la Complejidad de la Lesión

Caitlin E. Cox

March 13, 2014

News Daily News

DES Outcomes Vary by Diabetes Status, Lesion Complexity

Caitlin E. Cox

March 13, 2014

News Daily News

DUTCH PEERS Published: Third-Generation Zotarolimus, Everolimus Stents Equivalent

February 12, 2014

Presentation TCT 2013

Treatment of Complex Multivessel PCI. A New Sirolimus Chromium Cobalt Alloy DES. Study Design and Case Presentation

Presenter: Carlos Fernandez-Pereira

October 30, 2013

News Daily News

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

October 15, 2013

News Daily News

SES Show Advantage Over ZES, PES for Diabetic Patients

Yael L. Maxwell

June 20, 2013

News Conference News EuroPCR 2013

Novel Stent Helps Treat Bifurcation Lesions in FIM Registry

Jason Kahn

May 22, 2013

News Daily News

TWENTE: Still Few Differences between ZES and EES at 2 Years

L.A. McKeown

May 03, 2013

News Daily News

TWENTE: Sigue habiendo Pequeñas Diferencias entre los SLZ y los SLE a los 2 Años

L.A. McKeown

May 03, 2013

Advertisement

Debut of DES Failed to Alter Survival Benefit of CABG vs PCI in Multivessel Disease

TWENTE: Second-Generation DES Show Good Long-term Outcomes in Bifurcation Lesions

DES Linked With Lower In-Hospital Mortality Than BMS for All PCI Indications

Long-term Outcomes Worse for Patients with Coronary Artery Aneurysm After DES Implantation

Clinical Impact of DES Failure Depends on Timing

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

Long-term Outcomes of ‘Full Metal Jacket’ Stenting Appear Favorable

Las Mejoras en la Revascularización No Logran Reducir la Mortalidad por Todas las Causas en Japón

Improvements in Revascularization Reduce Cardiac Death, MI and Repeat Revascularization, but not All-Cause Mortality in Japan

Los Resultados SLF Varían según el Estado de la Diabetes y la Complejidad de la Lesión

DES Outcomes Vary by Diabetes Status, Lesion Complexity

DUTCH PEERS Published: Third-Generation Zotarolimus, Everolimus Stents Equivalent

Treatment of Complex Multivessel PCI. A New Sirolimus Chromium Cobalt Alloy DES. Study Design and Case Presentation

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

SES Show Advantage Over ZES, PES for Diabetic Patients

Novel Stent Helps Treat Bifurcation Lesions in FIM Registry

TWENTE: Still Few Differences between ZES and EES at 2 Years

TWENTE: Sigue habiendo Pequeñas Diferencias entre los SLZ y los SLE a los 2 Años

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content